Shultz, Mitchell
Chorbajian, Abraham
Zohouralen, Ala
Article History
Received: 18 July 2023
Accepted: 12 September 2023
First Online: 6 October 2023
Declarations
:
: Dr. Shultz: Aerie, R; Alchemy Vision, O; Allergan, C; Avellino Lab, C; Bausch and Lomb, C, R, L; BVI, R; Cloud Break, R; Glaukos, C, R, L; Glint Pharma, C; HDMD, C; HDMD, C; Imprimis/Harrow, C; Ivantis, C, L; New World Medical, C, R; Ocuphire Pharm, C; Sight Sciences, C, L; SOMED, C; SUN Pharm, C; Tarsus, R; Twenty Twenty, C; Zeiss, C. (C, consulting fees; R, research fees; L, lecture fees). Mr. Chorbajian: no competing interests. Ms. Zohouralen: no competing interests.
: The study was conducted according to the tenets of the Helsinki Declaration of 1964, local ethics guidelines (Western IRB), and HIPAA privacy practices. All patients gave informed consent prior to undergoing surgery, and their data were analyzed in a retrospective anonymized fashion.